平均血小板体积在慢性阻塞性肺疾病急性加重期呼吸衰竭患者中的应用价值

王胜奇

doi:10.13201/j.issn.1009-5918.2017.12.015

平均血小板体积在慢性阻塞性肺疾病急性加重期呼吸衰竭患者中的应用价值

王胜奇^,

- 首都医科大学宣武医院急诊科(北京, 100053)

详细信息

通讯作者: 王胜奇,E-mail:wsq.cums@163.com

中图分类号: R563.8

收稿日期: 2017-11-09

The value of mean platelet volume in patients with respiratory failure due to acute exacerbation of chronic obstructive pulmonary disease

WANG Shengqi^,

- Department of Emergency, Xuanwu Hospital Capital Medical University, Beijing, 100053, China

More Information

Corresponding author: WANG Shengqi, E-mail: wsq.cums@163.com

Received Date: 09 November 2017

摘要

摘要: 目的:探索平均血小板体积(MPV)对慢性阻塞性肺疾病(COPD)急性加重期呼吸衰竭患者的意义。方法:选取2015-04-01-2016-11-01期间就诊于我院急诊科的COPD急性加重期呼吸衰竭患者92例,其中Ⅰ型呼吸衰竭51例,Ⅱ型呼吸衰竭41例。所有患者在入院后立即查血常规、C反应蛋白(CRP)、血气分析。同时有40名健康体检者作为对照组,年龄、性别、体重指数(BMI)、吸烟史与研究组匹配。比较各组MPV、血常规、血气等各参数关系。结果:Ⅰ型呼吸衰竭组MPV (10.6±1.3)及Ⅱ型呼吸衰竭组MPV (10.1±1.6)显著高于对照组MPV (8.9±0.8);MPV与PO₂有明显相关性(r=0.440,P<0.01),MPV与乳酸有明显相关性(r=0.430,P<0.01);MPV与白细胞计数(WBC)有弱相关性(r=0.218,P<0.05),MPV与中性细胞百分比、CRP、PCO₂、PH值、血红蛋白、红细胞压积及血小板计数均无明显相关性。结论:在COPD急性加重期呼吸衰竭患者中,MPV升高可以反映患者缺氧及组织低灌注情况,MPV与炎症指标相关性不显著。
- 慢性阻塞性肺疾病 /
- 呼吸衰竭 /
- 平均血小板体积 /
- 乳酸
Abstract: Objective:To explore the significance of mean platelet volume (MPV) in patients with respiratory failure due to acute exacerbation of chronic obstructive pulmonary disease.Method:Ninty-two patients patients with respiratory failure due to acute exacerbation of chronic obstructive pulmonary disease were eligible to be enrolled from April 1 st, 2015 to November 1 st, 2016 in emergency treatment of XUANWU hospital, including 51 cases of type I respiratory failure, 41 cases with type Ⅱ respiratory failure.Routine blood test, C reactive protein (CRP) and blood gas analysis were made immediately after admission.At the same time, 40 healthy people were served as controls, with age, sex, body mass index (BMI), smoking history matched with the study group.The relationship of MPV, blood routine, blood gas and other parameters in each group was compared.Result:MPV of typeⅠ respiratory failure group (10.6±1.3) and type Ⅱ respiratory failure group (10.1±1.6) were significantly higher than the MPV of control group (8.9±0.8);there was significant correlation between MPV and PO₂ (r=0.440, P<0.01);There was significant correlation between MPV and lactic acid (r=0.430, P<0.01);MPV and white cell count (WBC) had weak correlation (r=0.218, P<0.05);There were no significant correlation between MPV and CRP, PCO₂, neutrophil percentage, pH, hemoglobin, hematocrit and platelet counts.Conclusion:In patients with respiratory failure due to acute exacerbation of COPD, elevated MPV may reflect hypoxia and low tissue perfusion, and there is no significant correlation between MPV and inflammatory markers.
- chronic obstructive pulmonary disease /
- respiratory failure /
- mean platelet volume /
- lactic acid

HTML全文

参考文献(16)

[1]	Hardie J A, Vollmer W M, Buist A S, et al.Respiratory symptoms and obstructive pulmonary disease in a population aged over 70years[J].Respir Med, 1999:186-195.
[2]	Michaud C M, Murray C J, Bloom B R, et al.Burden of disease implications for future research[J].JAMA, 2001, 285:535-539.
[3]	Sullivan S D, Ramsey S D, Lee T A, et al.The economic burden of COPD[J].Chest, 2000, 117:5S-9S.
[4]	Park Y, Schoene N, Harris W, et al.Mean platelet volume as an indicator of platelet activation:methodological issues[J].Platelets, 2002, 13:301-306.
[5]	Gasparyan A Y, Ayvazyan L, Mikhailidis D P, et al.Mean platelet volume:a link between thrombosis and inflammation?[J].Curr Pharm Des, 2011, 17:47-58.
[6]	Vizioli L, Muscari S, Muscari A, et al.The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases[J].Int J Clin Pract, 2009, 63:1509-1515.
[7]	Kapsoritakis A N, Koukourakis M I, Sfiridaki A, et al.Mean platelet volume:a useful marker of inflammatory bowel disease activity[J].Am J Gastroenterol, 2001, 96:776-781.
[8]	Kisacik B, Tufan A, Kalyoncu U, et al.Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis[J].Joint Bone Spine, 2008, 75:291-294.
[9]	Barnes P J, Celli B R.Systemic manifestations and comorbidities of COPD[J].Eur Respir J, 2009, 33:1165-1185.
[10]	Wang R, Cao Z, Li Y, et al.Mean platelet volume provides an additive value in differentiating congestive heart failure from chronic obstructive pulmonary disease[J].Int J Cardiol, 2015, 179:201-202.
[11]	Wang R T, Li J Y, Cao Z G, et al.Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease[J].Respirology, 2013, 18:1244-1248.
[12]	Agapakis D I, Massa E V, Hantzis I, et al.The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation[J].Respirol Care, 2016, 61:44-49.
[13]	Zhang M, Li Y L, Zhang J, et al.Mean platelet volume is elevated in exacerbated and convalescent COPD patients[J].Clin Chim Acta, 2015, 451:227-231.
[14]	Malerba M, Olivini A, Radaeli A, et al.Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease[J].Current Med Res Opinipon, 2016, 32:885-891.
[15]	Onder I, Topcu S, D9kmetas H S, et al.Platelet aggregation size and volume in chronic obstructive pulmonary disease.Materia Medica Polona[J].Polish J Med Pharmacy, 1997, 29:11-13.
[16]	Reeves S R, Gozal D.Platelet-activating factor receptor and respiratory and metabolic responses to hypoxia and hypercapnia[J].Res Physiol Neurobiol, 2004, 141:13-20.